While some findings suggest an increased risk of hepatic steatosis and fibrosis in acromegaly, others indicate a protective effect of GH against lipid accumulation in the liver, which complicates the assessment of potential bidirectional associations between acromegaly and MASLD. The gene discussed is GH1; the disease is fatty liver disease.